The Eighth International Childhood Acute Lymphoblastic Leukemia Workshop ('Ponte di legno meeting') report: Vienna, Austria, April 27-28, 2005. (Q44627350)

From Wikidata

Jump to navigation Jump to search

scientific article published in January 2006

Language	Label	Description	Also known as
English	The Eighth International Childhood Acute Lymphoblastic Leukemia Workshop ('Ponte di legno meeting') report: Vienna, Austria, April 27-28, 2005.	scientific article published in January 2006

Statements

scholarly article

1 reference

Europe PubMed Central

4 December 2017

The Eighth International Childhood Acute Lymphoblastic Leukemia Workshop ('Ponte di legno meeting') report: Vienna, Austria, April 27-28, 2005. (English)

1 reference

Europe PubMed Central

4 December 2017

0 references

1 reference

based on heuristic

inferred from title

0 references

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

Christine J Harrison

6

1 reference

Europe PubMed Central

4 December 2017

author name string

Gadner H

1

1 reference

Europe PubMed Central

4 December 2017

Masera G

2

1 reference

Europe PubMed Central

4 December 2017

Schrappe M

3

1 reference

Europe PubMed Central

4 December 2017

Eden T

4

1 reference

Europe PubMed Central

4 December 2017

Benoit Y

5

1 reference

Europe PubMed Central

4 December 2017

Nachman J

7

1 reference

Europe PubMed Central

4 December 2017

Pui CH

8

1 reference

Europe PubMed Central

4 December 2017

publication date

1 January 2006

1 reference

Europe PubMed Central

4 December 2017

1 reference

Europe PubMed Central

4 December 2017

20

1 reference

Europe PubMed Central

4 December 2017

9-17

1 reference

Europe PubMed Central

4 December 2017

1

1 reference

Europe PubMed Central

4 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404016

0 references

Meeting report: International Childhood ALL Workshop: Memphis, TN, 3-4 December 1997.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

21 January 2018

International collaboration on childhood leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

21 January 2018

Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

21 January 2018

'Ponte di Legno' Working Group--report on the Fifth International Childhood Acute Lymphoblastic Leukemia Workshop: Vienna, Austria, 29 April - 1 May 2002.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

21 January 2018

The best way to use asparaginase in childhood acute lymphatic leukaemia--still to be defined?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

21 January 2018

Anti-asparaginase antibodies following E. coli asparaginase therapy in pediatric acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

21 January 2018

Asparaginase pharmacodynamics differ by formulation among children with newly diagnosed acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

21 January 2018

A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

21 January 2018

Drug monitoring of PEG-asparaginase treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

21 January 2018

Asparaginase pharmacokinetics after intensive polyethylene glycol-conjugated L-asparaginase therapy for children with relapsed acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

21 January 2018

Treatment-related leukaemia--a clinical and scientific challenge

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

21 January 2018

Possible carcinogenic effect of 6-mercaptopurine on bone marrow stem cells: relation to thiopurine metabolism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

21 January 2018

High incidence of secondary brain tumours after radiotherapy and antimetabolites.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

21 January 2018

All children have a right to full access to treatment for cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

21 January 2018

Amplification of AML1 on a duplicated chromosome 21 in acute lymphoblastic leukemia: a study of 20 cases.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

21 January 2018

Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983-1995.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

21 January 2018

Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Nordic Society of Pediatric Haematology and Oncology (NOPHO).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

21 January 2018

Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980-1997. Medical Research Council Childhood Leukaemia Working Party.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

21 January 2018

Results of Therapy for Acute Lymphoblastic Leukemia in Black and White Children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

21 January 2018

Folate pathway gene expression differs in subtypes of acute lymphoblastic leukemia and influences methotrexate pharmacodynamics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

21 January 2018

A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

21 January 2018

Various types of rearrangements target TLX3 locus in T-cell acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

21 January 2018

HOX11L2 expression defines a clinical subtype of pediatric T-ALL associated with poor prognosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

21 January 2018

Split-signal FISH for detection of chromosome aberrations in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

21 January 2018

Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

21 January 2018

t(5;14)/HOX11L2-positive T-cell acute lymphoblastic leukemia. A collaborative study of the Groupe Français de Cytogénétique Hématologique (GFCH).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

21 January 2018

Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

21 January 2018

Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

21 January 2018

Origins of leukaemia in children with Down syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

21 January 2018

The management of neoplastic disorders of haematopoiesis in children with Down's syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

21 January 2018

Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are nonrandom and may be associated with outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

21 January 2018

Amplification of AML1 in acute lymphoblastic leukemia is associated with a poor outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

21 January 2018

Amplification of the ABL gene in T-cell acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

21 January 2018

Long-term results of large prospective trials in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

7 January 2021

based on heuristic

inferred from DOI database lookup

International Childhood Acute Lymphoblastic Leukemia Workshop: Sausalito, CA, 30 November-1 December 2000

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

7 January 2021

based on heuristic

inferred from DOI database lookup

Ponte di Legno Working Group: statement on the right of children with leukemia to have full access to essential treatment and report on the Sixth International Childhood Acute Lymphoblastic Leukemia Workshop

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

7 January 2021

based on heuristic

inferred from DOI database lookup

The seventh international childhood acute lymphoblastic leukemia workshop report: Palermo, Italy, January 29--30, 2005

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypersensitivity or development of antibodies to asparaginase does not impact treatment outcome of childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

7 January 2021

based on heuristic

inferred from DOI database lookup

Co-operative study group for childhood acute lymphoblastic leukemia (COALL): long-term follow-up of trials 82, 85, 89 and 92

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

7 January 2021

based on heuristic

inferred from DOI database lookup

Statement by members of the Ponte di Legno Group on the right of children to have full access to essential treatment for acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

7 January 2021

based on heuristic

inferred from DOI database lookup

A formulary for pediatric oncology in developing countries

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term results of treatment studies for childhood acute lymphoblastic leukemia: Pediatric Oncology Group studies from 1986-1994

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunologic, cytogenetic, and clinical characterization of childhood acute lymphoblastic leukemia with the t(1;19) (q23; p13) or its derivative

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical significance of translocation t(1;19) in childhood acute lymphoblastic leukemia in the context of contemporary therapies: a report from the Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

7 January 2021

based on heuristic

inferred from DOI database lookup

ABL oncogene amplification with p16(INK4a) gene deletion in precursor T-cell acute lymphoblastic leukemia/lymphoma: report of the first case

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute leukaemia in children with Down syndrome: a population-based Nordic study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

7 January 2021

based on heuristic

inferred from DOI database lookup

Down syndrome and leukemia: new insights into the epidemiology, pathogenesis, and treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

7 January 2021

based on heuristic

inferred from DOI database lookup

Lymphoblast biology and outcome among children with Down syndrome and ALL treated on CCG-1952

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404016

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2404016

1 reference

Europe PubMed Central

4 December 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

4 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44627350&oldid=1586506435"